Comparison of a β-lactam alone versus β-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis
Open Access
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 134 (4), 413-421
- https://doi.org/10.1016/s0022-3476(99)70197-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Management of Pulmonary Disease in Patients with Cystic FibrosisNew England Journal of Medicine, 1996
- Treatment of Pseudomonas lung infection in cystic fibrosis with piperacillin plus tobramycin versus ceftazidime monotherapy: Preliminary communicationPediatric Pulmonology, 1989
- Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosisThe Journal of Pediatrics, 1988
- Controlled trial of aztreonam vs. tobramycin and azlocillin for acute pulmonary exacerbations of cystic fibrosisThe Pediatric Infectious Disease Journal, 1988
- Comparison of piperacillin alone versus piperacillin plus tobramycin for treatment of respiratory infections in children with cystic fibrosisPediatric Pulmonology, 1988
- Immediate and Prolonged Clinical Efficacy of Ceftazidime versus Ceftazidime plus Tobramycin in Chronic Pseudomonas aeruginosa Infection in Cystic FibrosisScandinavian Journal of Infectious Diseases, 1986
- Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosisJournal of Antimicrobial Chemotherapy, 1983
- A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosisThe Journal of Pediatrics, 1981
- Standardization of lung function testing in children: Proceedings and recommendations of the GAP conference Committee, cystic fibrosis foundationThe Journal of Pediatrics, 1980
- Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?The Journal of Pediatrics, 1980